CCR7 and Alzheimer disease: The deletion of CCR7 in 5xFAD (a mouse model of AD) mice leads to accelerated cognitive decline and Aβ accumulation that is improved by anti-CD25 treatment (which depletes both activated and regulatory T cells) in old mice [51].